0 items USD 0.00Search
Your search for "globaldata pharmapoint colorectal cancer china drug forecast market analysis 2023" gave back 220445 results.
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Targeted Drugs for Colorectal Cancer market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
March 2023
Price: USD 4,480.00
There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Publisher' newest research report, the “Metastatic Colorectal Cancer Drug Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
According to our publisher latest study, the global Targeted Drugs for Colorectal Cancer market size was valued at USD million in 2022 and is...
Catalog:
GIR
March 2023
Price: USD 3,480.00
Metastatic colorectal cancer (mCRC) is a type of colorectal cancer that has spread to other parts of the body, such as the liver, lungs, or bones. It...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Colorectal Cancer - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2018
Price: USD 2,500.00
Colorectal Cancer - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
June 2018
Price: USD 2,500.00
A method for diagnosing hereditary colorectal cancer The global Molecular Diagnosis of Hereditary Colorectal Cancer market was valued at US$ million...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Colorectal Cancer - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
June 2020
Price: USD 2,500.00
Colorectal cancer therapeutics market trends, there are a number of factors providing major impetus to the growth of these drugs. The global...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
December 2022
Price: USD 2,500.00
